Skip to main content

Table 2 Outcomes at 12 weeks and 26 weeks follow-up

From: Can we predict which patients with plantar heel pain are more likely to benefit from insoles? A secondary exploratory analysis of a randomized controlled trial

  Follow-up at 12 weeks Follow-up at 26 weeks
  Sham insole group
n = 68
mean (SD) unless otherwise indicated
Custom made insole group
n = 66
mean (SD) unless otherwise indicated
Usual care group
N = 39
mean (SD) unless otherwise indicated
Sham insole group
n = 68
mean (SD) unless otherwise indicated
Custom made insole group
n = 66
mean (SD) unless otherwise indicated
Usual care group
N = 38
mean (SD) unless otherwise indicated
FFI total score, 0–100 30.3 (21.0) 30.8 (23.2) 30.2 (24.6) 24.6 (24.1) 25.0 (23.1) 22.2 (26.5)
FFI total MID*, N (%) 48 (70.6) 45 (68.2) 27 (69.2) 53 (77.9) 53 (80.3) 30 (78.9)
Recovered**,
N (%)
25 (36.8) 24 (36.4) 15 (32.6) 39 (57.4) 35 (53.0) 21 (55.3)
First step pain, 0–10 5.0 (3.0) 5.0 (3.0) 4.0 (0.0) 3.0 (3.0) 4.0 (4.0) 3.0 (3.0)
First step pain MID, N (%)*** 38 (55.9) 39 (59.1) 23.0 (59.0) 48 (70.6) 43 (65.2) 28 (73.7)
  1. * A patient was considered to have reached a minimal important improvement in FFI if their FFI total score at follow-up was at least 6.5 (the minimal important difference) lower than at baseline
  2. **A patient is defined as recovered if they answered ‘the complaints have completely disappeared or they are strongly improved’
  3. ***A patient was considered to have reached a minimal important improvement in first step pain if their first step pain score follow-up was at least 1.9 (the minimal important difference) lower (improved) than at baseline